Experimental and Clinical Gastroenterology | 2021
S-ademetionine in the treatment of non-alcoholic fatty liver disease (NAFLD)
Abstract
The experimental and clinic data supporting S- ademetionin application in NAFLD complex therapy were presented. The therapy corrects an oxidative stress in hepatocytes and transforms the nutrition behavior in patients with excessive body weight when depressive syndrome is developed.